Our team of leaders, engineers, and scientists across the globe work to reliably and rapidly operate our immune cell foundry to generate cell products that produce positive outcomes in patients.
The Artisan team is passionate about crafting customized cell engineering solutions to solve the most challenging problems in human health applications. We believe that by leveraging rapid advances in DNA reading and writing technologies at the interface of engineering and biology we will deliver more efficacious and safe cell products to the market.
XSeed Capital believes in the creative destruction unleashed by technological innovators. Our portfolio companies boast significant differentiation that creates unique customer value.
Northpond Ventures is a science-driven venture capital firm. We partner with leading scientists, academics, and entrepreneurs to imagine and impact society through extraordinary discoveries within life sciences and technology.
Takeda Ventures focuses on high-caliber therapeutic and platform-based opportunities around the world. We invest in early-stage opportunities that complement Takeda’s pipeline and products.
Interested in joining our rapidly growing team to work on cross-disciplinary projects in the area of immune cell engineering? Be part of our mission to engineer patient-focused cell therapeutics that will significantly improve outcomes.